Page last updated: 2024-11-05

trimethadione and Biliary Tract Diseases

trimethadione has been researched along with Biliary Tract Diseases in 1 studies

Trimethadione: An anticonvulsant effective in absence seizures, but generally reserved for refractory cases because of its toxicity. (From AMA Drug Evaluations Annual, 1994, p378)
trimethadione : An oxazolidinone that is 1,3-oxazolidine-2,4-dione substituted by methyl groups at positions 3, 5 and 5. It is an antiepileptic agent.

Biliary Tract Diseases: Diseases in any part of the BILIARY TRACT including the BILE DUCTS and the GALLBLADDER.

Research Excerpts

ExcerptRelevanceReference
" The serum DMO/TMO ratio at 4 h after oral dosing in patients of PTBD and renal dysfunction was not significantly changed in comparison with the ratio reported previously in healthy volunteers."1.28The metabolism and excretion of trimethadione in patients with percutaneous transhepatic biliary drainage and renal dysfunction. ( Fukao, K; Ishikawa, A; Iwasaki, Y; Misawa, S; Tanaka, E; Yamamoto, Y, 1989)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tanaka, E1
Ishikawa, A1
Yamamoto, Y1
Fukao, K1
Iwasaki, Y1
Misawa, S1

Other Studies

1 other study available for trimethadione and Biliary Tract Diseases

ArticleYear
The metabolism and excretion of trimethadione in patients with percutaneous transhepatic biliary drainage and renal dysfunction.
    Journal of pharmacobio-dynamics, 1989, Volume: 12, Issue:3

    Topics: Adult; Aged; Bile; Biliary Tract Diseases; Dimethadione; Female; Half-Life; Humans; Kidney Diseases;

1989